{
    "medicine_id": "9d967615ba4ed7f7b9dcd8e48f7ac34009420912",
    "platform_id": "DB08949",
    "metadata": {
        "name": "DermaNIC",
        "composition": "Inositol nicotinate",
        "clinical_particulars": {
            "therapeutic_indications": "Indicated as a dietary supplement for the source of niacin Has been investigated for potential beneficial effects on serum lipids In Europe inositol hexanicotinate is indicated as a patented drug known as Hexopal which is therapeutically indicated for the symptomatic relief of severe intermittent claudication and Raynaud s phenomenon",
            "contraindications": {
                "disease": "NOAEL is 4000mg Inositol nicotinate can cause muscle pain headache redness of face nausea vomiting edema and rash",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Inositol nicotinate mediates a vasodilatory lipid lowering and fibrinolytic effect on the cardiovascular system Like other niacins inositol nicotinate is a lipid regulating agent that reduces the levels of plasma triglycerides atherogenic apolipoprotein B apoB containing lipoproteins VLDL LDL and lipoprotein a while increasing antiatherogenic apoA I containing HDL levels A19560",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB13967",
                        "description": "The therapeutic efficacy of Inositol nicotinate can be decreased when used in combination with Patent Blue"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Inositol nicotinate may increase the vasodilatory activities of Isosorbide mononitrate"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}